How Parenteral Formulation Development Turns a Molecule Into a Sterile, Stable Injectable
Parenteral formulation development is the work of turning an active ingredient into an injectable product that can be given safely, stays stable on the shelf,
Parenteral formulation development is the work of turning an active ingredient into an injectable product that can be given safely, stays stable on the shelf,
Ocular drug delivery is not a single formulation problem. It is a system design problem created by the layered anatomy of the eye, rapid clearance
Protein formulation development is not a buffer recipe exercise. It is the design of a complete product system that has to preserve molecular structure, biological
Selecting the right solubility enhancement strategies is one of the earliest formulation decisions for a poorly soluble drug candidate. Low solubility can limit the amount
The Challenge: Treating Meibomian Gland Dysfunction in Dry Eye Disease Dry eye disease is a multi-parametric disorder of the tear fluid and ocular surface that
The Challenge: Delivering Water-Soluble Proteins to the Ocular Surface The ocular surface is rich in a diverse array of proteins, each playing a role in
Selecting an ophthalmic formulation CRO requires a different evaluation process than selecting a general formulation provider. Ocular drug programs face challenges that are specific to
The Challenge: Frequent Intravitreal Injections Retinal disorders, including choroidal neovascularization, diabetic retinopathy, and age-related macular degeneration, can cause irreversible loss of vision. The therapeutics that
Bacterial resistance in ocular microbial disease is a recurring problem. Successive generations of antibiotic exposure establish mutations, and emergent multidrug-resistant species render existing antimicrobial treatments
Selecting a formulation development partner is a critical decision for biotech and pharmaceutical companies moving a molecule toward clinical development. The right partner can help